VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MKL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MKLMarkel Corporation
$1956.08$24.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMKLQuarterly Financials

Markel Corporation (MKL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Markel Corporation (MKL) quarterly income statement — complete revenue, gross profit & net income history

MKL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue3.55B4.22B4.39B4.41B3.33B3.84B4.5B3.71B4.52B4.56B3.41B4.13B3.61B4.07B3.18B1.9B2.63B3.77B2.74B3.48B
Revenue Growth %6.74%9.87%-2.51%18.87%-26.38%-15.79%31.78%-10.1%25.14%12.05%7.38%117.55%37.32%7.87%16.25%-45.47%-10%15.72%-3.81%12.06%
Medical Costs & Claims1.17B1.28B1.98B1.96B1.82B1.24B1.9B1.84B1.82B2.19B2.01B1.78B1.65B1.84B1.73B1.62B1.56B1.52B1.46B1.33B
Medical Cost Ratio %32.86%30.41%45.03%44.5%54.78%32.33%42.22%49.69%40.38%48%58.9%43.09%45.8%45.29%54.46%85.19%59.42%40.24%53.46%38.26%
Gross Profit2.38B2.94B2.41B2.45B1.5B2.6B2.6B1.87B2.69B2.37B1.4B2.35B1.96B2.23B1.45B280.98M1.07B2.25B1.27B2.15B
Gross Margin %67.14%69.59%54.97%55.5%45.22%67.67%57.78%50.31%59.62%52%41.1%56.91%54.2%54.71%45.54%14.81%40.58%59.76%46.54%61.74%
Gross Profit Growth %58.48%12.98%-7.25%31.14%-44.16%9.59%85.26%-20.52%37.65%6.5%-3.09%735.95%83.4%-1.24%13.75%-86.92%-34.51%18.02%-12.69%1.97%
Operating Expenses2.66B2.2B1.43B1.59B1.35B1.88B1.39B1.5B1.35B1.37B1.34B1.44B1.29B1.33B1.31B1.4B1.13B1.12B1.03B1.13B
OpEx / Revenue %74.84%52.19%32.66%35.95%40.48%48.83%30.97%40.45%29.92%29.93%39.12%34.91%35.6%32.57%41.35%73.94%43.13%29.56%37.62%32.41%
Depreciation & Amortization43.51M044.06M51.21M46.94M46.49M46.46M44.24M44.28M44.25M47.55M44.42M44.4M43.79M43.42M45.52M46.05M41.99M39.27M39.73M
Combined Ratio %107.7%82.6%77.7%80.45%95.26%81.16%73.19%90.13%70.3%77.93%98.02%78%81.4%77.85%95.81%159.13%102.55%69.8%91.08%70.67%
Operating Income-273.33M734.16M978.44M862.36M157.75M723.51M1.21B366.09M1.34B1.01B67.5M907.87M671.53M901.47M133.22M-1.12B-66.95M1.14B244.08M1.02B
Operating Margin %-7.7%17.4%22.3%19.55%4.74%18.84%26.81%9.87%29.7%22.07%1.98%22%18.6%22.15%4.19%-59.13%-2.55%30.2%8.92%29.33%
Operating Income Growth %-273.27%1.47%-18.89%135.56%-88.24%-28.14%1687.11%-59.68%99.8%11.69%-49.33%180.93%1103.06%-20.9%-45.42%-209.93%-109.2%12.49%-58.21%-13.18%
EBITDA-229.82M784.17M1.02B913.57M204.69M770.01M1.25B410.33M1.39B1.05B115.05M952.29M715.93M945.26M176.63M-1.08B-20.9M1.18B283.35M1.06B
EBITDA Margin %-6.47%18.58%23.31%20.71%6.15%20.05%27.84%11.06%30.68%23.04%3.37%23.07%19.83%23.22%5.55%-56.73%-0.79%31.31%10.36%30.47%
Interest Expense50.89M50.02M50.68M53.08M52.14M52.79M53.36M52.6M45.55M43.87M44.55M47.22M49.44M48.97M47.35M50.05M49.69M48.17M46.45M46.57M
Non-Operating Income0-50.02M-50.68M-53.08M-52.14M-52.79M-53.36M-52.6M-45.55M-43.87M-44.55M-47.22M-49.44M-48.97M-47.35M-50.05M-49.69M-48.17M-46.45M-46.57M
Pretax Income-269.94M734.16M978.44M862.36M157.75M723.51M1.21B366.09M1.34B1.01B67.5M907.87M671.53M901.47M133.22M-1.12B-66.95M1.14B244.08M1.02B
Pretax Margin %-7.6%17.4%22.3%19.55%4.74%18.84%26.81%9.87%29.7%22.07%1.98%22%18.6%22.15%4.19%-59.13%-2.55%30.2%8.92%29.33%
Income Tax-65.58M152.07M214.66M185.17M28.4M162.08M259.41M76.24M292.56M212.71M14.23M191.94M133.73M191.9M16.46M-238.95M-18.14M264.56M54.41M217.11M
Effective Tax Rate %24.3%20.71%21.94%21.47%18.01%22.4%21.5%20.83%21.8%21.13%21.09%21.14%19.91%21.29%12.36%21.3%27.09%23.21%22.29%21.28%
Net Income-212.29M576.81M751.34M657.15M121.71M549.18M904.96M267.7M1.03B769.31M42.59M695.51M488.65M689.71M59.59M-915.8M-51.74M871.13M188.07M792.11M
Net Margin %-5.98%13.67%17.13%14.9%3.66%14.3%20.11%7.21%22.69%16.87%1.25%16.85%13.53%16.94%1.87%-48.27%-1.97%23.08%6.88%22.77%
Net Income Growth %-274.42%5.03%-16.98%145.48%-88.13%-28.61%2024.77%-61.51%109.8%11.54%-28.53%175.95%1044.42%-20.83%-68.31%-215.61%-109.02%2.81%-58.46%-14.07%
EPS (Diluted)-18.9048.7559.2549.6712.0838.7466.2518.6275.4356.486.1250.0937.2649.059.01-69.15-3.6662.4415.0957.02
EPS Growth %-256.46%25.84%-10.57%166.76%-83.99%-31.41%982.52%-62.83%102.44%15.15%-32.08%172.44%1118.03%-21.44%-40.29%-221.27%-108.71%5.24%-51.37%-13.28%
EPS (Basic)-18.9048.9559.4449.8012.1138.8366.4018.6675.5656.676.1450.2037.3349.219.03-69.15-3.6662.6515.1257.12
Diluted Shares Outstanding11.23M11.83M12.73M12.73M12.84M12.93M13.02M13.08M13.16M13.29M13.35M13.41M13.47M13.54M13.6M13.61M13.65M13.75M13.79M13.82M